New treatments for chronic obstructive pulmonary disease and viable formulation/device options for inhalation therapy

S Onoue, S Misaka, Y Kawabata… - Expert Opinion on Drug …, 2009 - Taylor & Francis
Chronic obstructive pulmonary disease (COPD) is an increasingly important cause of
morbidity and mortality, pathological features of which are pulmonary inflammation and …
被引用次数：34 相关文章

New treatments for chronic obstructive pulmonary disease and viable formulation/device options for inhalation therapy

S Onoue, S Misaka, Y Kawabata… - Expert opinion on …, 2009 - pubmed.ncbi.nlm.nih.gov
Chronic obstructive pulmonary disease (COPD) is an increasingly important cause of
morbidity and mortality, pathological features of which are pulmonary inflammation and …

New treatments for chronic obstructive pulmonary disease and viable formulation/device options for inhalation therapy.

S Onoue, S Misaka, Y Kawabata… - Expert Opinion on Drug …, 2009 - europepmc.org
Chronic obstructive pulmonary disease (COPD) is an increasingly important cause of
morbidity and mortality, pathological features of which are pulmonary inflammation and …

New treatments for chronic obstructive pulmonary disease and viable formulation/device options for inhalation therapy

S Onoue, S Misaka, Y Kawabata… - Expert Opinion on Drug …, 2009 - hero.epa.gov
Chronic obstructive pulmonary disease (COPD) is an increasingly important cause of
morbidity and mortality, pathological features of which are pulmonary inflammation and …

[引用][C] New treatments for chronic obstructive pulmonary disease and viable formulation/device options for inhalation therapy

S Onoue, S Misaka, Y Kawabata… - Expert Opinion on Drug …, 2009 - cir.nii.ac.jp
New treatments for chronic obstructive pulmonary disease and viable formulation/device
options for inhalation therapy | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ …